BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33611763)

  • 1. Surgical outcomes of vitrectomy for breakthrough vitreous hemorrhage in eyes with exudative age-related macular degeneration.
    Iwase T; Baba T; Saito Y; Nizawa T; Yokouchi H; Kubota-Taniai M; Kitahashi M; Yamamoto S
    Int Ophthalmol; 2021 May; 41(5):1835-1844. PubMed ID: 33611763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Factors and Long-term Surgical Outcomes for Exudative Age-related Macular Degeneration with Breakthrough Vitreous Hemorrhage.
    Kim TY; Kang HG; Choi EY; Koh HJ; Kim SS; Lee JH; Kim M; Byeon SH; Lee CS
    Korean J Ophthalmol; 2020 Aug; 34(4):281-289. PubMed ID: 32783420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual outcomes of early and late vitrectomy for breakthrough vitreous hemorrhage associated with exudative age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jirarattanasopa P; Khongsakdinasarn N; Ratanasukon M; Bhurayanontachai P; Dangboon Tsutsumi W
    Medicine (Baltimore); 2023 Oct; 102(40):e35364. PubMed ID: 37800778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual outcomes of vitrectomy for polypoidal choroidal vasculopathy-related breakthrough vitreous haemorrhage.
    Lin HC; Yang CH; Yang CM;
    Eye (Lond); 2014 Jul; 28(7):797-806; quiz 807. PubMed ID: 24924445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of vitreous hemorrhage secondary to exudative age-related macular degeneration.
    Hasegawa T; Otani A; Sasahara M; Gotoh N; Ooto S; Tamura H; Yamashiro K; Tsujikawa A; Yoshimura N
    Am J Ophthalmol; 2010 Feb; 149(2):322-329.e1. PubMed ID: 20103057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of vitrectomy for breakthrough vitreous hemorrhage associated with age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jung JH; Lee JK; Lee JE; Oum BS
    Retina; 2010 Jun; 30(6):865-73. PubMed ID: 20182402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and outcomes of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy.
    Li MS; Tsen CL
    PLoS One; 2022; 17(12):e0279778. PubMed ID: 36584198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE INCIDENCE, CHARACTERISTICS, MANAGEMENT, PROGNOSIS, AND CLASSIFICATION OF BREAKTHROUGH VITREOUS HEMORRHAGE SECONDARY TO POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Zhao XY; Luo MY; Meng LH; Zhang WF; Li B; Wang EQ; Liu SZ; Yu WH; Chen YX
    Retina; 2021 Aug; 41(8):1675-1685. PubMed ID: 33395221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Kim JH; Kim JW; Kim CG; Lee DW
    Sci Rep; 2020 Jan; 10(1):359. PubMed ID: 31941971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitrectomy for exudative age-related macular degeneration with vitreous hemorrhage.
    Sakamoto T; Sheu SJ; Arimura N; Sameshima S; Shimura M; Uemura A; Kawano H; Wu TT; Kubota T; Sohma R; Noda Y
    Retina; 2010 Jun; 30(6):856-64. PubMed ID: 20182401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VITRECTOMY WITH SUBRETINAL INJECTION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR FOR SUBMACULAR HEMORRHAGE WITH OR WITHOUT VITREOUS HEMORRHAGE.
    Shi T; Wen J; Xia H; Chen H
    Retina; 2024 Jul; 44(7):1188-1195. PubMed ID: 38452260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term observation of vitrectomy without subretinal hemorrhage management for massive vitreous hemorrhage secondary to polypoidal choroidal vasculopathy.
    Li ZX; Hu YJ; Atik A; Lu L; Hu J
    Int J Ophthalmol; 2019; 12(12):1859-1864. PubMed ID: 31850169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator.
    Caporossi T; Bacherini D; Governatori L; Oliverio L; Di Leo L; Tartaro R; Rizzo S
    Acta Ophthalmol; 2022 Aug; 100(5):e1143-e1152. PubMed ID: 34609787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pars plana vitrectomy for regression of choroidal neovascularization with age-related macular degeneration.
    Ikeda T; Sawa H; Koizumi K; Yasuhara T; Yamasaki T
    Acta Ophthalmol Scand; 2000 Aug; 78(4):460-4. PubMed ID: 10990052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual prognosis of submacular hemorrhage secondary to age-related macular degeneration: A retrospective multicenter survey.
    Inoue N; Kato A; Araki T; Kimura T; Kinoshita T; Okamoto F; Murakami T; Mitamura Y; Sakamoto T; Miki A; Takamura Y; Matsubara H; Tsujinaka H; Gomi F; Yasukawa T
    PLoS One; 2022; 17(7):e0271447. PubMed ID: 35862313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous haemorrhage in massive hemorrhagic polypoidal choroidal vasculopathy: clinical characteristics and surgical outcomes: Vitreous hemorrhage in PCV.
    Narayanan R; Mithal K; Jalali S; Chhablani JK; Mathai A; Ali MH
    Int J Retina Vitreous; 2015; 1():25. PubMed ID: 27847618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of iOCT in Vitreoretinal Surgery for Dense Vitreous Hemorrhage in a Chinese Population.
    Tao J; Wu H; Chen Y; Mao J; Cheng D; Lin J; Shen L
    Curr Eye Res; 2019 Feb; 44(2):219-224. PubMed ID: 30299988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
    Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.